Arquivamento - Art. 36 §1° da LPI
#11.2
11/08/2022
RPI 2705
Application data
Number
112019017375Type
Filing
Publication
PCT
US2018018989 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 11/08/2022. We update with every new RPI gazette, published weekly.
Applicants
KURA ONCOLOGY, INC.
US
Inventors
A. G. (pessoa física)
US
C. S. (pessoa física)
US
IPC Classification
Priority claims
US
15/820,012 · 11/21/2017
US
15/820,157 · 11/21/2017
US
62/461,602 · 02/21/2017
US
62/507,749 · 05/17/2017
US
62/519,819 · 06/14/2017
US
62/596,653 · 12/08/2017
Abstract
A presente invenção refere-se ao campo da terapia contra o câncer. Especificamente, são providos métodos para o tratamento de câncer, por exemplo, linfoma periférico de células T (LPCT), com um inibidor de farnesiltransferase (FTI), os quais incluem determinar se o indivíduo provavelmente responderá ao tratamento com FTI tendo por base características da expressão gênica.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
11/08/2022
RPI 2705
#6.23
07/26/2022
RPI 2690
#15.35
10/13/2021
RPI 2649
#25.7
10/05/2021
RPI 2648
#1.3
03/31/2020
RPI 2569
#1.1
08/27/2019
RPI 2538
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.